Structure

Physi-Chem Properties

Molecular Weight:  648.29
Volume:  652.787
LogP:  4.827
LogD:  3.387
LogS:  -4.113
# Rotatable Bonds:  11
TPSA:  144.28
# H-Bond Aceptor:  10
# H-Bond Donor:  3
# Rings:  7
# Heavy Atoms:  10

MedChem Properties

QED Drug-Likeness Score:  0.113
Synthetic Accessibility Score:  6.696
Fsp3:  0.568
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.104
MDCK Permeability:  2.4643839424243197e-05
Pgp-inhibitor:  0.92
Pgp-substrate:  0.008
Human Intestinal Absorption (HIA):  0.1
20% Bioavailability (F20%):  0.591
30% Bioavailability (F30%):  0.245

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.456
Plasma Protein Binding (PPB):  96.130859375%
Volume Distribution (VD):  2.577
Pgp-substrate:  1.7686797380447388%

ADMET: Metabolism

CYP1A2-inhibitor:  0.032
CYP1A2-substrate:  0.914
CYP2C19-inhibitor:  0.197
CYP2C19-substrate:  0.421
CYP2C9-inhibitor:  0.845
CYP2C9-substrate:  0.005
CYP2D6-inhibitor:  0.005
CYP2D6-substrate:  0.055
CYP3A4-inhibitor:  0.883
CYP3A4-substrate:  0.489

ADMET: Excretion

Clearance (CL):  9.791
Half-life (T1/2):  0.657

ADMET: Toxicity

hERG Blockers:  0.848
Human Hepatotoxicity (H-HT):  0.985
Drug-inuced Liver Injury (DILI):  0.911
AMES Toxicity:  0.076
Rat Oral Acute Toxicity:  0.689
Maximum Recommended Daily Dose:  0.989
Skin Sensitization:  0.739
Carcinogencity:  0.346
Eye Corrosion:  0.003
Eye Irritation:  0.012
Respiratory Toxicity:  0.986

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC477188

Natural Product ID:  NPC477188
Common Name*:   [(1R,2R,6S,7S,8R,10S,11S,12R,16R,17R,18R)-6,7-dihydroxy-8-(hydroxymethyl)-4,18-dimethyl-14-[(1Z,3Z)-nona-1,3-dienyl]-5-oxo-16-prop-1-en-2-yl-9,13,15,19-tetraoxahexacyclo[12.4.1.01,11.02,6.08,10.012,16]nonadec-3-en-17-yl] benzoate
IUPAC Name:   [(1R,2R,6S,7S,8R,10S,11S,12R,16R,17R,18R)-6,7-dihydroxy-8-(hydroxymethyl)-4,18-dimethyl-14-[(1Z,3Z)-nona-1,3-dienyl]-5-oxo-16-prop-1-en-2-yl-9,13,15,19-tetraoxahexacyclo[12.4.1.01,11.02,6.08,10.012,16]nonadec-3-en-17-yl] benzoate
Synonyms:  
Standard InCHIKey:  CGSGRJNIABXQJQ-SIJGATCLSA-N
Standard InCHI:  InChI=1S/C37H44O10/c1-6-7-8-9-10-11-15-18-34-45-30-26-29-33(20-38,44-29)32(41)35(42)25(19-22(4)27(35)39)37(26,47-34)23(5)28(36(30,46-34)21(2)3)43-31(40)24-16-13-12-14-17-24/h10-19,23,25-26,28-30,32,38,41-42H,2,6-9,20H2,1,3-5H3/b11-10-,18-15-/t23-,25-,26+,28-,29+,30-,32-,33+,34?,35-,36-,37+/m1/s1
SMILES:  CCCCC/C=C\C=C/C12O[C@@H]3[C@@H]4[C@H]5[C@](O5)([C@H]([C@]6([C@H]([C@@]4(O1)[C@@H]([C@H]([C@]3(O2)C(=C)C)OC(=O)C7=CC=CC=C7)C)C=C(C6=O)C)O)O)CO
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   n.a.
PubChem CID:   122180652
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids
          • [CHEMONTID:0003494] Rhamnofolane and daphnane diterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO19476 Gnidia polycephala Species Thymelaeaceae Eukaryota roots n.a. n.a. PMID[26091146]
NPO19476 Gnidia polycephala Species Thymelaeaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO19476 Gnidia polycephala Species Thymelaeaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT98 Individual Protein HERG Homo sapiens Inhibition = 42.5 % PMID[26091146]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC477188 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC43304
1.0 High Similarity NPC477190
0.9804 High Similarity NPC61891
0.98 High Similarity NPC49297
0.9733 High Similarity NPC181924
0.9673 High Similarity NPC66193
0.9673 High Similarity NPC322420
0.9608 High Similarity NPC275477
0.9551 High Similarity NPC40138
0.9533 High Similarity NPC146310
0.947 High Similarity NPC251139
0.9423 High Similarity NPC325732
0.9423 High Similarity NPC324769
0.9359 High Similarity NPC471134
0.9281 High Similarity NPC154675
0.9156 High Similarity NPC475548
0.9156 High Similarity NPC475638
0.9156 High Similarity NPC290683
0.9032 High Similarity NPC11410
0.9026 High Similarity NPC471135
0.9007 High Similarity NPC477737
0.8981 High Similarity NPC323356
0.8981 High Similarity NPC471138
0.8981 High Similarity NPC326328
0.8981 High Similarity NPC309991
0.8976 High Similarity NPC254588
0.8896 High Similarity NPC51602
0.8896 High Similarity NPC471103
0.8854 High Similarity NPC322048
0.8854 High Similarity NPC318447
0.8839 High Similarity NPC283875
0.8839 High Similarity NPC469647
0.8839 High Similarity NPC138641
0.8839 High Similarity NPC22571
0.8839 High Similarity NPC469648
0.879 High Similarity NPC106895
0.879 High Similarity NPC323001
0.879 High Similarity NPC326235
0.8782 High Similarity NPC133430
0.8782 High Similarity NPC469477
0.8757 High Similarity NPC186746
0.875 High Similarity NPC478124
0.8734 High Similarity NPC477735
0.8726 High Similarity NPC472549
0.8726 High Similarity NPC21410
0.8726 High Similarity NPC473670
0.8726 High Similarity NPC282239
0.8718 High Similarity NPC233581
0.8718 High Similarity NPC145649
0.871 High Similarity NPC7095
0.8704 High Similarity NPC477491
0.8696 High Similarity NPC478073
0.8693 High Similarity NPC127857
0.8679 High Similarity NPC469399
0.8679 High Similarity NPC477736
0.8654 High Similarity NPC472398
0.8645 High Similarity NPC250046
0.8645 High Similarity NPC60509
0.8645 High Similarity NPC81698
0.8642 High Similarity NPC471493
0.8634 High Similarity NPC55744
0.8616 High Similarity NPC469417
0.8616 High Similarity NPC472393
0.8608 High Similarity NPC26033
0.8608 High Similarity NPC228204
0.8599 High Similarity NPC477905
0.8599 High Similarity NPC472548
0.8598 High Similarity NPC102465
0.859 High Similarity NPC165260
0.859 High Similarity NPC161239
0.859 High Similarity NPC476173
0.859 High Similarity NPC112216
0.859 High Similarity NPC198455
0.8581 High Similarity NPC132652
0.858 High Similarity NPC478125
0.8571 High Similarity NPC471100
0.8571 High Similarity NPC471107
0.8562 High Similarity NPC471102
0.8562 High Similarity NPC319404
0.8553 High Similarity NPC77493
0.8553 High Similarity NPC217091
0.8545 High Similarity NPC477488
0.8544 High Similarity NPC473414
0.8544 High Similarity NPC256142
0.8544 High Similarity NPC229545
0.8544 High Similarity NPC1173
0.8544 High Similarity NPC472030
0.8544 High Similarity NPC472022
0.8544 High Similarity NPC248265
0.8544 High Similarity NPC257213
0.8544 High Similarity NPC472005
0.8544 High Similarity NPC249471
0.8544 High Similarity NPC158333
0.8544 High Similarity NPC265395
0.8544 High Similarity NPC219419
0.8544 High Similarity NPC237549
0.8544 High Similarity NPC11588
0.8544 High Similarity NPC242262
0.8544 High Similarity NPC304876
0.8544 High Similarity NPC134685
0.8535 High Similarity NPC470153
0.8535 High Similarity NPC62792
0.8516 High Similarity NPC312393
0.8516 High Similarity NPC240115
0.8506 High Similarity NPC471139
0.8491 Intermediate Similarity NPC112523
0.8491 Intermediate Similarity NPC114357
0.8491 Intermediate Similarity NPC473611
0.8491 Intermediate Similarity NPC132599
0.8491 Intermediate Similarity NPC469730
0.8491 Intermediate Similarity NPC473632
0.8491 Intermediate Similarity NPC155329
0.8491 Intermediate Similarity NPC114410
0.8491 Intermediate Similarity NPC5115
0.8491 Intermediate Similarity NPC259144
0.8471 Intermediate Similarity NPC91730
0.8471 Intermediate Similarity NPC470245
0.8471 Intermediate Similarity NPC473214
0.8471 Intermediate Similarity NPC254558
0.8466 Intermediate Similarity NPC329960
0.8466 Intermediate Similarity NPC150893
0.8466 Intermediate Similarity NPC295408
0.8442 Intermediate Similarity NPC95449
0.8442 Intermediate Similarity NPC477894
0.8438 Intermediate Similarity NPC70344
0.8434 Intermediate Similarity NPC477469
0.8434 Intermediate Similarity NPC477473
0.8434 Intermediate Similarity NPC477466
0.8434 Intermediate Similarity NPC477471
0.8431 Intermediate Similarity NPC291599
0.8431 Intermediate Similarity NPC97947
0.8431 Intermediate Similarity NPC472576
0.8431 Intermediate Similarity NPC87448
0.8431 Intermediate Similarity NPC118080
0.8431 Intermediate Similarity NPC16912
0.8431 Intermediate Similarity NPC27377
0.8431 Intermediate Similarity NPC41481
0.8428 Intermediate Similarity NPC77719
0.8418 Intermediate Similarity NPC101043
0.8418 Intermediate Similarity NPC306799
0.8418 Intermediate Similarity NPC197037
0.8418 Intermediate Similarity NPC478123
0.8418 Intermediate Similarity NPC469415
0.8418 Intermediate Similarity NPC298072
0.8408 Intermediate Similarity NPC473215
0.8408 Intermediate Similarity NPC476975
0.8397 Intermediate Similarity NPC469513
0.8393 Intermediate Similarity NPC469421
0.8387 Intermediate Similarity NPC34943
0.8385 Intermediate Similarity NPC469771
0.8377 Intermediate Similarity NPC183540
0.8377 Intermediate Similarity NPC182869
0.8375 Intermediate Similarity NPC469422
0.8375 Intermediate Similarity NPC34066
0.8375 Intermediate Similarity NPC469456
0.8373 Intermediate Similarity NPC469420
0.8366 Intermediate Similarity NPC97667
0.8366 Intermediate Similarity NPC90614
0.8366 Intermediate Similarity NPC275592
0.8366 Intermediate Similarity NPC100913
0.8366 Intermediate Similarity NPC171207
0.8354 Intermediate Similarity NPC303429
0.8354 Intermediate Similarity NPC125033
0.8354 Intermediate Similarity NPC222102
0.8344 Intermediate Similarity NPC327031
0.8344 Intermediate Similarity NPC217918
0.8333 Intermediate Similarity NPC177940
0.8333 Intermediate Similarity NPC277053
0.8333 Intermediate Similarity NPC174982
0.8333 Intermediate Similarity NPC70403
0.8333 Intermediate Similarity NPC470159
0.8333 Intermediate Similarity NPC470157
0.8333 Intermediate Similarity NPC200471
0.8333 Intermediate Similarity NPC29704
0.8333 Intermediate Similarity NPC472571
0.8333 Intermediate Similarity NPC96903
0.8333 Intermediate Similarity NPC469349
0.8333 Intermediate Similarity NPC158663
0.8333 Intermediate Similarity NPC171525
0.8333 Intermediate Similarity NPC301946
0.8333 Intermediate Similarity NPC476973
0.8333 Intermediate Similarity NPC472575
0.8333 Intermediate Similarity NPC473088
0.8333 Intermediate Similarity NPC472572
0.8333 Intermediate Similarity NPC184817
0.8333 Intermediate Similarity NPC472568
0.8333 Intermediate Similarity NPC471104
0.8313 Intermediate Similarity NPC472658
0.8313 Intermediate Similarity NPC472657
0.8312 Intermediate Similarity NPC325078
0.8282 Intermediate Similarity NPC477623
0.828 Intermediate Similarity NPC170668
0.828 Intermediate Similarity NPC20255
0.828 Intermediate Similarity NPC473602
0.8269 Intermediate Similarity NPC163719
0.8269 Intermediate Similarity NPC125106
0.8269 Intermediate Similarity NPC475759
0.8269 Intermediate Similarity NPC80895
0.8269 Intermediate Similarity NPC476974
0.8269 Intermediate Similarity NPC472570

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC477188 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8274 Intermediate Similarity NPD7799 Discontinued
0.8208 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.815 Intermediate Similarity NPD8407 Phase 2
0.8081 Intermediate Similarity NPD8368 Discontinued
0.7974 Intermediate Similarity NPD7966 Clinical (unspecified phase)
0.7764 Intermediate Similarity NPD7236 Approved
0.7753 Intermediate Similarity NPD8434 Phase 2
0.7701 Intermediate Similarity NPD8470 Clinical (unspecified phase)
0.7667 Intermediate Similarity NPD8360 Approved
0.7667 Intermediate Similarity NPD8435 Approved
0.7667 Intermediate Similarity NPD8361 Approved
0.7636 Intermediate Similarity NPD7239 Suspended
0.7582 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7459 Intermediate Similarity NPD8424 Clinical (unspecified phase)
0.7459 Intermediate Similarity NPD8150 Discontinued
0.7394 Intermediate Similarity NPD8486 Clinical (unspecified phase)
0.7374 Intermediate Similarity NPD7685 Pre-registration
0.7234 Intermediate Similarity NPD8485 Approved
0.7225 Intermediate Similarity NPD7057 Phase 3
0.7225 Intermediate Similarity NPD7058 Phase 2
0.7215 Intermediate Similarity NPD5952 Clinical (unspecified phase)
0.7209 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7196 Intermediate Similarity NPD7700 Phase 2
0.7196 Intermediate Similarity NPD7699 Phase 2
0.7184 Intermediate Similarity NPD7075 Discontinued
0.7157 Intermediate Similarity NPD8462 Phase 1
0.7151 Intermediate Similarity NPD3751 Discontinued
0.715 Intermediate Similarity NPD8319 Approved
0.715 Intermediate Similarity NPD8320 Phase 1
0.7128 Intermediate Similarity NPD6535 Approved
0.7128 Intermediate Similarity NPD6534 Approved
0.7119 Intermediate Similarity NPD3787 Discontinued
0.7111 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.711 Intermediate Similarity NPD7819 Suspended
0.7104 Intermediate Similarity NPD8313 Approved
0.7104 Intermediate Similarity NPD8312 Approved
0.7098 Intermediate Similarity NPD7435 Discontinued
0.7066 Intermediate Similarity NPD6190 Approved
0.7056 Intermediate Similarity NPD3818 Discontinued
0.7049 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7041 Intermediate Similarity NPD8389 Clinical (unspecified phase)
0.7029 Intermediate Similarity NPD4965 Approved
0.7029 Intermediate Similarity NPD4966 Approved
0.7029 Intermediate Similarity NPD4967 Phase 2
0.7025 Intermediate Similarity NPD6007 Clinical (unspecified phase)
0.7013 Intermediate Similarity NPD5125 Phase 3
0.7013 Intermediate Similarity NPD5126 Approved
0.7005 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.6995 Remote Similarity NPD6559 Discontinued
0.6989 Remote Similarity NPD4381 Clinical (unspecified phase)
0.697 Remote Similarity NPD7874 Approved
0.697 Remote Similarity NPD7875 Clinical (unspecified phase)
0.6961 Remote Similarity NPD7228 Approved
0.6957 Remote Similarity NPD7808 Phase 3
0.6954 Remote Similarity NPD37 Approved
0.6954 Remote Similarity NPD6801 Discontinued
0.6949 Remote Similarity NPD6234 Discontinued
0.6943 Remote Similarity NPD6782 Approved
0.6943 Remote Similarity NPD6778 Approved
0.6943 Remote Similarity NPD6780 Approved
0.6943 Remote Similarity NPD6776 Approved
0.6943 Remote Similarity NPD6777 Approved
0.6943 Remote Similarity NPD6779 Approved
0.6943 Remote Similarity NPD6781 Approved
0.6936 Remote Similarity NPD4380 Phase 2
0.6931 Remote Similarity NPD8404 Phase 2
0.6923 Remote Similarity NPD7698 Approved
0.6923 Remote Similarity NPD7697 Approved
0.6923 Remote Similarity NPD7696 Phase 3
0.6914 Remote Similarity NPD5760 Phase 2
0.6914 Remote Similarity NPD5761 Phase 2
0.691 Remote Similarity NPD5494 Approved
0.6906 Remote Similarity NPD7473 Discontinued
0.6902 Remote Similarity NPD6764 Approved
0.6902 Remote Similarity NPD7251 Discontinued
0.6902 Remote Similarity NPD6765 Approved
0.6889 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6888 Remote Similarity NPD7870 Phase 2
0.6888 Remote Similarity NPD7871 Phase 2
0.6885 Remote Similarity NPD7074 Phase 3
0.6875 Remote Similarity NPD3817 Phase 2
0.6875 Remote Similarity NPD5402 Approved
0.6872 Remote Similarity NPD7199 Phase 2
0.6869 Remote Similarity NPD7701 Phase 2
0.6854 Remote Similarity NPD5537 Clinical (unspecified phase)
0.6853 Remote Similarity NPD7999 Approved
0.685 Remote Similarity NPD7801 Approved
0.6848 Remote Similarity NPD6797 Phase 2
0.6848 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6839 Remote Similarity NPD6599 Discontinued
0.6832 Remote Similarity NPD7930 Approved
0.6831 Remote Similarity NPD5844 Phase 1
0.6831 Remote Similarity NPD7054 Approved
0.6811 Remote Similarity NPD7240 Approved
0.681 Remote Similarity NPD7961 Discontinued
0.6805 Remote Similarity NPD4628 Phase 3
0.6793 Remote Similarity NPD7472 Approved
0.6784 Remote Similarity NPD6799 Approved
0.6768 Remote Similarity NPD7211 Clinical (unspecified phase)
0.6763 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6758 Remote Similarity NPD6166 Phase 2
0.6758 Remote Similarity NPD6168 Clinical (unspecified phase)
0.6758 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6755 Remote Similarity NPD6785 Approved
0.6755 Remote Similarity NPD6784 Approved
0.6744 Remote Similarity NPD2532 Approved
0.6744 Remote Similarity NPD2534 Approved
0.6744 Remote Similarity NPD2533 Approved
0.6742 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6742 Remote Similarity NPD3882 Suspended
0.674 Remote Similarity NPD6232 Discontinued
0.6732 Remote Similarity NPD2629 Approved
0.6723 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6689 Remote Similarity NPD2181 Clinical (unspecified phase)
0.6686 Remote Similarity NPD6591 Clinical (unspecified phase)
0.6686 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6686 Remote Similarity NPD7458 Discontinued
0.6685 Remote Similarity NPD8127 Discontinued
0.6685 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6667 Remote Similarity NPD5403 Approved
0.6667 Remote Similarity NPD1934 Approved
0.6667 Remote Similarity NPD7497 Discontinued
0.6667 Remote Similarity NPD8151 Discontinued
0.6647 Remote Similarity NPD5401 Approved
0.6646 Remote Similarity NPD3764 Approved
0.6635 Remote Similarity NPD8155 Clinical (unspecified phase)
0.6632 Remote Similarity NPD6212 Phase 3
0.6632 Remote Similarity NPD6213 Phase 3
0.6632 Remote Similarity NPD6214 Clinical (unspecified phase)
0.6629 Remote Similarity NPD8455 Phase 2
0.6627 Remote Similarity NPD7266 Discontinued
0.6627 Remote Similarity NPD2346 Discontinued
0.6616 Remote Similarity NPD6823 Phase 2
0.661 Remote Similarity NPD7411 Suspended
0.6608 Remote Similarity NPD2575 Approved
0.6608 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6591 Remote Similarity NPD3226 Approved
0.6581 Remote Similarity NPD4198 Discontinued
0.6561 Remote Similarity NPD7741 Discontinued
0.6552 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6543 Remote Similarity NPD7319 Approved
0.6541 Remote Similarity NPD7457 Clinical (unspecified phase)
0.6536 Remote Similarity NPD2801 Approved
0.6529 Remote Similarity NPD5762 Approved
0.6529 Remote Similarity NPD5763 Approved
0.6527 Remote Similarity NPD230 Phase 1
0.652 Remote Similarity NPD7783 Phase 2
0.652 Remote Similarity NPD7782 Clinical (unspecified phase)
0.6519 Remote Similarity NPD3749 Approved
0.6516 Remote Similarity NPD690 Clinical (unspecified phase)
0.6512 Remote Similarity NPD8166 Discontinued
0.6509 Remote Similarity NPD2799 Discontinued
0.65 Remote Similarity NPD7492 Approved
0.6486 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6481 Remote Similarity NPD7736 Approved
0.6478 Remote Similarity NPD3412 Clinical (unspecified phase)
0.6474 Remote Similarity NPD7274 Clinical (unspecified phase)
0.6461 Remote Similarity NPD7028 Phase 2
0.646 Remote Similarity NPD6616 Approved
0.6456 Remote Similarity NPD6054 Approved
0.6453 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6447 Remote Similarity NPD2182 Approved
0.6429 Remote Similarity NPD6355 Discontinued
0.6429 Remote Similarity NPD969 Suspended
0.642 Remote Similarity NPD7078 Approved
0.642 Remote Similarity NPD6273 Approved
0.6415 Remote Similarity NPD8516 Approved
0.6415 Remote Similarity NPD8513 Phase 3
0.6415 Remote Similarity NPD8515 Approved
0.6415 Remote Similarity NPD8517 Approved
0.6413 Remote Similarity NPD6959 Discontinued
0.6402 Remote Similarity NPD5740 Clinical (unspecified phase)
0.6402 Remote Similarity NPD6085 Phase 2
0.6395 Remote Similarity NPD1549 Phase 2
0.6395 Remote Similarity NPD970 Clinical (unspecified phase)
0.6393 Remote Similarity NPD919 Approved
0.6386 Remote Similarity NPD7008 Discontinued
0.6382 Remote Similarity NPD5345 Clinical (unspecified phase)
0.6382 Remote Similarity NPD8285 Discontinued
0.6378 Remote Similarity NPD5711 Approved
0.6378 Remote Similarity NPD5710 Approved
0.6375 Remote Similarity NPD6370 Approved
0.6374 Remote Similarity NPD2935 Discontinued
0.6374 Remote Similarity NPD2796 Approved
0.6374 Remote Similarity NPD7768 Phase 2
0.6364 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6364 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6364 Remote Similarity NPD4141 Clinical (unspecified phase)
0.6358 Remote Similarity NPD7507 Approved
0.6354 Remote Similarity NPD1465 Phase 2
0.6353 Remote Similarity NPD7097 Phase 1
0.6347 Remote Similarity NPD2313 Discontinued
0.6344 Remote Similarity NPD3926 Phase 2
0.6343 Remote Similarity NPD3300 Phase 2
0.6337 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6337 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6337 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6337 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6337 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6337 Remote Similarity NPD6002 Phase 3

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data